Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
Dow 12,874.00 +72.81 0.57%
S&P 500 1,351.77 +9.13 0.68%
Nasdaq 2,931.39 +27.51 0.95%
Ticker Volume Price Price Delta
STOXX 50 2,491.54 +10.78 0.43%
FTSE 100 5,905.70 +53.31 0.91%
DAX 6,738.47 +45.51 0.68%
Ticker Volume Price Price Delta
Nikkei 8,985.79 -13.39 -0.15%
TOPIX 779.62 -2.06 -0.26%
Hang Seng 20,851.70 -35.71 -0.17%
Gold 1,717.60 -0.42%
EUR-USD 1.3152 -0.2620%
Nasdaq 2,931.39 +0.95%
Dow 12,874.00 +0.57%
S&P 500 1,351.77 +0.68%
FTSE 100 5,905.70 +0.91%
STOXX 50 2,491.54 +0.43%
DAX 6,738.47 +0.68%
Oil (WTI) 100.44 -0.47%
U.S. 10-year 1.957% -0.028
BAC:US 8.25 +2.23%
CSCO:US 20.03 +0.68%
Live TV
Loading player, please wait...

CCLA's Bevan Recommends Apple, Amgen and Novo Nordisk

March 15 (Bloomberg) -- James Bevan, chief investment officer at CCLA Investment Management, talks about his equities strategy. Bevan, who oversees $10 billion, speaks with Bloomberg's Rishaad Salamat in London. (Source: Bloomberg)

Advertisement